Perbedaan J Resources Asia Pasifik Tbk. dan Organon Pharma Indonesia Tbk.: J Resources Asia Pasifik Tbk. diperdagangkan di Rp580 (kapitalisasi pasar 15,48 T, volume 24 jam 68,06 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: J Resources Asia Pasifik Tbk. jauh lebih besar — sekitar 148,3× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| PSAB | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 15,48 T | 104,4 M |
Volume | 68,06 jt | — |
Lot | 680,58 rb | — |
Perputaran | 39,21 M | — |
Harga Rata-rata | 576,11 | — |
Nilai Transaksi | 39,21 M | — |
Harga Ekuilibrium Indikatif | 580 | — |
Volume Ekuilibrium Indikatif | 21,68 rb | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT J Resources Asia Pasifik Tbk (the Company) was established under the name of PT Pelita Sejahtera Abadi Tbk on January 14, 2002. PT Pelita Sejahtera Abadi Tbk is an Indonesia-based service company. The Company operates food courts and provides catering services. In addition, it is engaged in the transportation, telecommunication and real estate sectors. The Company is headquartered in Semarang, Indonesia.
Selengkapnya di halaman PSAB →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →